Clinical Trial: Utility of right ventricular myocardial performance index measured by intraoperative transesophageal echocardiography for assessing right ventricular function during cardiac surgery (Japan)

Tokyo, March 23 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061008) titled 'Utility of right ventricular myocardial performance index (RVMPI) measured by intraoperative transesophageal echocardiography for assessing right ventricular function during cardiac surgery' on March 23.

Study Type: Observational

Primary Sponsor: Institute - Osaka Metropolitan University

Condition: Condition - Patients planned for cardiac surgery with cardiopulmonary bypass Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - This study aims to evaluate the impact of intraoperative RVMPI, measured in patients undergoing cardiac surgery with cardiopulmonary bypass, on postoperative outcomes. Basic objectives2 - Efficacy

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Patients planned for cardiac surgery with cardiopulmonary bypass at Osaka Metropolitan University Hospital Key exclusion criteria - 1. Contraindication to transesophageal echocardiography (TEE) 2. Contraindication to any of the planned anesthetic agents (propofol, fentanyl, remifentanil, or rocuronium) Target Size - 180

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 03 Month 16 Day Anticipated trial start date - 2026 Year 04 Month 01 Day Last follow-up date - 2031 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069812

Disclaimer: Curated by HT Syndication.